Consolidated Balance Sheets (unaudited) - USD ($) $ in Thousands	Mar. 31, 2019	Dec. 31, 2018
Assets
Cash and due from banks	$ 4,981	$ 5,915
Federal funds sold and other interest bearing deposits with banks	183,537	148,556
Cash and cash equivalents	188,518	154,471
Investment securities available for sale, at fair value	30,567	31,278
Investment securities held to maturity (fair value of $1,346 at March 31, 2019 and $1,292 at December 31, 2018)	1,126	1,113
Total investment securities	31,693	32,391
Loans held for sale	0	419
Loans, net of unearned income	1,298,697	1,241,157
Less: Allowance for loan losses	(19,810)	(19,075)
Net loans	1,278,887	1,222,082
Accrued interest receivable	5,760	5,191
Premises and equipment, net	6,865	6,783
Other real estate owned (OREO)	5,156	5,124
Restricted stock, at cost	5,858	5,858
Bank owned life insurance (BOLI)	25,956	25,809
Deferred tax asset	6,392	6,511
Other assets	3,080	2,759
Total Assets	1,558,165	1,467,398
Deposits
Noninterest-bearing deposits	375,326	360,329
Interest-bearing deposits	889,982	823,544
Total deposits	1,265,308	1,183,873
FHLBNY borrowings	104,650	104,650
Subordinated debentures	13,403	13,403
Accrued interest payable	1,786	1,390
Other liabilities	11,903	9,086
Total liabilities	1,397,050	1,312,402
Equity
Preferred stock,1,000,000 shares authorized, $1,000 liquidation value Series B non-cumulative convertible; 560 shares and 1,224 shares outstanding at March 31, 2019 and December 31, 2018, respectively	560	1,224
Common stock, $.10 par value; authorized 15,000,000 shares; Issued: 11,044,485 shares at March 31, 2019 and 10,953,081 shares at December 31, 2018	1,104	1,095
Additional paid-in capital	113,561	112,807
Retained earnings	47,624	42,079
Accumulated other comprehensive loss	(272)	(633)
Treasury stock, 284,522 shares at March 31, 2019 and December 31, 2018, at cost	(3,015)	(3,015)
Total shareholders’ equity	159,562	153,557
Noncontrolling interest in consolidated subsidiaries	1,553	1,439
Total equity	161,115	154,996
Total liabilities and equity	$ 1,558,165	$ 1,467,398